Warren Isakow MD
Critical Care Medicine, Interventional Pulmonology, Pleural Disease
Assistant Professor, Internal Medicine, Washington University in St. Louis School of Medicine
Join to View Full Profile
4921 Parkview PlSte 8BSaint Louis, MO 63110
Phone+1 314-454-8917
Fax+1 314-454-2200
Dr. Isakow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2000 - 2003
University of the WitwatersrandClass of 1998
Certifications & Licensure
AZ State Medical License 2018 - 2027
WV State Medical License 2019 - 2026
AR State Medical License 2024 - 2026
VA State Medical License 2018 - 2026
PA State Medical License 2018 - 2026
OH State Medical License 2018 - 2026
MO State Medical License 2003 - 2026
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Clinical Trials
- Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 8 citationsRisk Factors for Loss of Lung Sliding in a Medical Intensive Care Population With Acute Respiratory Failure.Christopher Mallow, Warren Isakow
Journal of Bronchology & Interventional Pulmonology. 2019-04-01 - 11 citationsDiscrepancies in measuring bladder volumes with bedside ultrasound and bladder scanning in the intensive care unit: A pilot study.Donna Prentice, Carrie Sona, Brian Wessman, Enyo Ablordeppey, Warren Isakow
Journal of the Intensive Care Society. 2018-05-01 - 8 citationsThe peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by ...Delphine L. Chen, Howard J. Huang, Derek E. Byers, Adrian Shifren, Bryan G Belikoff
Plos One. 2018-02-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
